Wafaa M Rashed, Chair and Founder of Pan-African PGS Education and Research Initiative, shared a post on LinkedIn:
“The Cost of Gene Therapy – and Why Africa Must Be Part of the Solution.
A new blog in Dr. Ernest Ahamah, MLS.D ’s Gene Therapy Advocacy Series
“Change does not begin when access is guaranteed.
It begins when we decide that equity is non-negotiable — and start building the systems today.”
Gene therapy holds extraordinary promise, yet its cost threatens to turn innovation into exclusion — especially for African countries. But high prices should not mark the end of the conversation. They should mark its beginning.
In his latest blog, “Cost of Gene Therapy: Exploring Sustainable Financing Models for LMICs,” Dr. Ernest Ahamah 🇬🇭 continues his powerful advocacy for Africa’s right to access advanced therapies.
This piece confronts one of the most difficult questions head-on:
How can African health systems afford gene therapy – and why must they prepare to do so now?
Dr. Ahamah unpacks the structural drivers of gene therapy costs and makes a compelling case for rethinking value, financing, and policy models through an African lens. He highlights innovative pathways – from pooled procurement and outcome-based payments to regional manufacturing and global solidarity – that can move gene therapy from aspiration to action.
This blog is part of Dr. Ernest’s growing Gene Therapy Advocacy Series, grounded in a firm belief that Africa must not be a late adopter of life-saving science. His message is clear:
Africa does not need to wait for perfect conditions – it needs vision, policy courage, and sustained work starting today.
At PAPERI, we are proud to amplify this voice. We believe that African-led thought leadership, strong policy frameworks, and ethical commitment are essential to ensuring that gene therapy evolves as a tool for equity – not privilege.
The future will not arrive by chance.
It will be built – deliberately, persistently, and together.
Join us in supporting Dr. Ernest Ahamah and all African advocates working to ensure that gene therapy is not a distant promise, but a shared future.”
More posts featuring Wafaa M Rashed on OncoDaily.